
Korean hospitals gain approval for SK biopharmaceuticals' epilepsy drug ahead of domestic launch
Two university hospitals have received approval this year for the therapeutic use of SK biopharmaceuticals’ epilepsy drug cenobamate (development name YKP3089 tablets), drawing the industry’s attention. According to the Ministry of Food and Drug Safety ( …